Common Contracts

1 similar Licensing Agreement contracts

Licensing agreement for ESETEC-based production of antibody fragment PB2452
Licensing Agreement • June 14th, 2024

PhaseBio obtains the right to use both WACKER’s ESETEC-based production strain and WACKER’s ESETEC technology to manufacture and commercialize the antibody fragment.

AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!